INTEGRATED DELIVERY DEVICE FOR CONTINUOUS GLUCOSE SENSOR

Patent №

US 11,246,990

Granted

2022-02-15

Filed 2018

Owner

DEXCOM, INC.

Lab

AI components

2

planning · evo

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

15906946

Systems and methods for integrating a continuous glucose sensor, including a receiver, a medicament delivery device, and optionally a single point glucose monitor are provided. Manual integrations provide for a physical association between the devices wherein a user (for example, patient or doctor) manually selects the amount, type, and/or time of delivery. Semi-automated integration of the devices includes integrations wherein an operable connection between the integrated components aids the user (for example, patient or doctor) in selecting, inputting, calculating, or validating the amount, type, or time of medicament delivery of glucose values, for example, by transmitting data to another component and thereby reducing the amount of user input required. Automated integration between the devices includes integrations wherein an operable connection between the integrated components provides for full control of the system without required user interaction.

PlanningEvolutionary computationA61M 5/31525A61B 5/0002A61B 5/14532A61B 5/14865A61B 5/4839A61M 5/1723A61M 11/00A61M 15/0001+11 more

AI classification

Evolutionary computation0.98
Planning0.97
Natural language0.03
Machine learning0.01
Knowledge representation0.00
Speech0.00
AI hardware0.00
Vision0.00

Ownership

DEXCOM, INC.

assignment · 466160911

Assignors

BRAUKER, JAMES H, TAPSAK, MARK A, SAINT, SEAN T, KAMATH, APURV U, NEALE, PAUL V, SIMPSON, PETER C, MENSINGER, MICHAEL R, MARKOVIC, DUBRAVKA

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC